Skinbiotherapeutics Share Discussion Threads

[slartybartfaster] 10/3/2021 12:03

All of Sheedy's predictions are useless. It's easy making money off him though. Just do the opposite. You can't fail.

[slartybartfaster] 10/3/2021 12:02

Yes. They have been taken down.

[madaboutmed] 10/3/2021 11:51

And we have just passed the 40p mark yet again. He is useless mate.

[tonyevo256] 10/3/2021 11:42

There have been some leaks about the trial on another site, it's impossible to authenticate but I've chucked the kitchen sink at this one just in case.

[dekle] 10/3/2021 11:25

Was there some leaks about the success of the current trials?

[blah blah] 10/3/2021 10:48

Socionomics - just a reminder that on 17 February you said 28-29p would be hit in the next two to three weeks. You are already wrong as your three weeks are up, and that's despite a bear market for many stocks and the price here is barely changed throughout.

Stick your 25 years reading tea leaves and waddle off, would you?

[pgaffney] 10/3/2021 10:28

toyin
Thanks

[pgaffney] 10/3/2021 09:53

elrico
How do i get to view your own private board
My son tried to get on the study but was rejected!
Shame as it would have given me inside info
Anyone know someone on the trial and how is it progressing

[slartybartfaster] 10/3/2021 09:08

They issues 1, they may not need to until they have finished. Even so, it's remarkable how many times it's rebounded off 35p and still one clown predicted 29p.

[madaboutmed] 09/3/2021 23:26

Slarty is right. Winclove make the product but SBTX brought them the idea. Winclove validated the formula and have the manufacturing rights.

[slartybartfaster] 09/3/2021 22:54

There isnt one. SA said they buy the product from winclove. There is no profit share.

[slartybartfaster] 09/3/2021 22:53

Whenever has Sheedy been right? Let's call the fool for who he really is.He has yet another username because all the other a he used to predict the share price demise have all gone into hiding on the OPTI TROLL BB. Anything goes there. Even blatant lies are the norm.

[belgrano2] 09/3/2021 22:52

One question I have and I'd appreciate anyones answers on it. Clearly SBTX have been in partnership with winclove on getting this bacterial formulation for the study.

If it appears after results are in to be a great success, whats the financial split.
Clearly this does have a major potential bearing on company performance.

Winclove certainly have a lot to offer being the bigger player of this potential arrangement.

[nobbygnome] 09/3/2021 21:02

The following was posted by socio on February 17th.

'SBTX might be the best investment on the market, but you can't fight the natural ebb and flow of price action.

28-29p will be hit over the next two to three weeks. In that fact I have no doubt.'

So there has to be a precipitate fall tomorrow or he/she is WRONG! The fact he/she said that they have no doubt in 'that fact' is very amusing I think we all know what the outcome will be....

[slartybartfaster] 09/3/2021 18:38

We all know who sociomoronic is. We know why he has adopted another username. Don't we Sheedy. His other usernames were telling us to sell at 5p. He knows nobody is going to take him seriously with another share price prediction.

[elrico] 09/3/2021 18:28

I wish I have a £1 every time a new pseudonym rocked up with a declining share price prediction, and I would not need to buy the underlying shares to turn a profit. Regardless of the short term price movement, or whether I remain correct on the 35p rebound (7) intraday events by my poor maths, ANY short term retrace will be just that, short term. There are a few key events in the pipe, any of which could land at any time. Psoriasis/and other studies will shock the market, which I AM CONVINCED OF. Moreover, I don't think the market has yet wised that the study is no longer just about the efficiency of the psoriasis probiotic. There is real potential for more than one probiotic emerging from this study, a significant bonus because any number of the related conditions opens up multi-billion $ markets.

There is a big question on every investor's minds. Will we get an update midway through the study, or will the company make us wait until it has completed the study, or will it make us wait until the paper is published? IMHO, there is no reason why the company cannot update just after the study has been completed. It will almost certainly already have enough data at the midpoint, nevermind the endpoint. And the paper is really more about sales and marketing material. We already know the USA psoriasis association have a desire to ''run with it.'' Moreover, Stuart explained they were disappointed not to be included in the study. I am sure they will be kept informed.

This brings me to the next questions. Will a formulation be produced and made ready for the soft-launch, and will it be before Q3?

IMHO, Seneca is creating most of the sell volume. Had it not been for them, we would be nearer 50p not 40p.

[madaboutmed] 09/3/2021 15:09

Spot on Slarty

[slartybartfaster] 09/3/2021 14:46

Btw sociomorinic. I'm not a trader and I'm not new either. Keep to the facts rather than make assumptions to support your flawed case.

[slartybartfaster] 09/3/2021 14:44

Sociomoronic, i was just as naive at 6p using the same logic. Go figure. Chart predictions have been posted here and everywhere else countless times. You know what I've learned.? They are useless in more ways than they are useful. They may assist weak holders by persuading them to sell and trade, but ill stick with what works for me, and that's buy accumulate and hold as commercial traction kicks in. I bet my percentage gains are greater than yours. Care to make a bet?

[atlantic57] 09/3/2021 13:53

It is always good to listen to am opposing point of view,if it is offered in a constructive fashion.Finding Advfn boards with good two discussion appears to be impossible.